Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults
Condition: Malaria,Falciparum Interventions: Biological: R21/Matrix-M vaccination; Drug: DHA-PIP; Drug: PQ Sponsor: University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2022 Category: Research Source Type: clinical trials
